Amygdalin Reverses Macrophage PANoptosis Induced by Drug-Resistant Escherichia coli
Journal of Microbiology and Biotechnology · 28.10.2023 · 33 (10) · 1281-1291
DOI: 10.4014/jmb.2306.06030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, online erschienen am 28.07.2023. Verfasst von Xue Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China. Hauptthemen laut MEDLINE: Amygdalin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of China, Biosafety Laboratory of Integrated Chinese and Western Medicine at Zhejiang Chinese Medicine University, Zhejiang Province Traditional Chinese Medicine Science and Technology project.
Abstract (Originalsprache)
Infectious diseases caused by drug-resistant Escherichia coli (E. coli) pose a critical concern for medical institutions as they can lead to high morbidity and mortality rates. In this study, amygdalin exhibited anti-inflammatory and antioxidant activities, as well as other potentials. However, whether it could influence the drug-resistant E. coli-infected cells remained unanswered. Amygdalin was therefore tested in a cellular model in which human macrophages were exposed to resistant E. coli. Apoptosis was measured by flow cytometry and the lactate dehydrogenase (LDH) assay. Western immunoblotting and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) were used to quantify interleukin-18 (IL-18), interleukin-1β (IL-1β), and interleukin-6 (IL-6). The production of reactive oxygen species (ROS) in macrophages was detected by ROS kit. The expression of panapoptotic proteins in macrophages was measured by qRT-PCR and Western immunoblotting. Drug-Resistant E. coli inhibited cell viability and enhanced apoptosis in the cellular model. In cells treated with amygdalin, this compound can inhibit cell apoptosis and reduce the expression of pro - inflammatory cytokines such as IL-1β, IL-18 and IL-6. Additionally, it decreases the production of PANoptosis proteins, Furthermore, amygdalin lowered the levels of reactive oxygen species induced by drug-resistant E. coli, in cells, demonstrating its antioxidant effects. Amygdalin, a drug with a protective role, alleviated cell damage caused by drug-resistant E. coli in human macrophages by inhibiting the PANoptosis signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P.R. China.
- School of Basic Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, P. R. China.
Förderung
- Natural Science Foundation of China
- Biosafety Laboratory of Integrated Chinese and Western Medicine at Zhejiang Chinese Medicine University
- Zhejiang Province Traditional Chinese Medicine Science and Technology project
- Zhejiang Chinese Medical University
Zitieren
APA
Yan, X., Jin, L., Zhou, H., Wan, H., Wan, H., & Yang, J. (2023). Amygdalin Reverses Macrophage PANoptosis Induced by Drug-Resistant Escherichia coli. Journal of Microbiology and Biotechnology, 33(10), 1281-1291. https://doi.org/10.4014/jmb.2306.06030
Vancouver
Yan X, Jin L, Zhou H, Wan H, Wan H, Yang J. Amygdalin Reverses Macrophage PANoptosis Induced by Drug-Resistant Escherichia coli. Journal of Microbiology and Biotechnology. 2023;33(10):1281-1291. doi:10.4014/jmb.2306.06030
BibTeX
@article{Yan2023,
author = {Yan, Xue and Jin, Liang and Zhou, Huifen and Wan, Haofang and Wan, Haitong and Yang, Jiehong},
title = {Amygdalin Reverses Macrophage PANoptosis Induced by Drug-Resistant Escherichia coli},
journal = {Journal of Microbiology and Biotechnology},
year = {2023},
volume = {33},
number = {10},
pages = {1281--1291},
doi = {10.4014/jmb.2306.06030}
}
EUVIMED